---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-089366"
form_type: "8-K/A"
ticker: "ASTH"
cik: "0001083446"
company_name: "Astrana Health, Inc."
filed_at: "2023-08-09T23:59:59+00:00"
generated_at: "2026-06-11T21:17:17.936600+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# ApolloMed Q2 revenue up 29% to $348.2M, net income +10%; guidance reaffirmed

## Summary
- Total revenue $348.2M (+29% YoY); net income attributable to ApolloMed $13.2M (+10%); adjusted EBITDA $35.8M (+44%).
- Care Partners revenue $325.2M (+32%); segment operating income surged 250% to $27.8M.
- FY2023 guidance reaffirmed: total revenue $1.3B-$1.5B; adjusted EBITDA $120M-$160M; diluted EPS $0.95-$1.20.
- Agreed to acquire Texas Independent Providers (120+ PCPs); partnered with IntraCare (425+ providers) with $25M convertible note.
- Filing corrects balance sheet items: income taxes payable to $20.4M, total liabilities to $443.6M, mezzanine equity to $13.8M.

## SEC filing metadata
- accession: 0001104659-23-089366
- form_type: 8-K/A
- ticker: ASTH
- cik: 0001083446
- company_name: Astrana Health, Inc.
- filed_at: 2023-08-09T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1083446/000110465923089366/0001104659-23-089366-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1083446/000110465923089366/tm2323203d1_8ka.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-089366
- JSON: https://secwatch.observer/filing/0001104659-23-089366.json
- Plain text: https://secwatch.observer/filing/0001104659-23-089366.txt

## Key facts
- Earnings Releases
  Astrana Health, Inc. reported six months ended June 30, 2023 results: revenue $685.5 million, net income $26.3 million. Guidance reaffirmed.
  - Period: six months ended June 30, 2023
  - Revenue: $685.5 million
  - Net income: $26.3 million
  - Guidance: reaffirmed
  - Result: reported results
  source text: Financial Highlights for Six Months Ended June 30, 2023: All comparisons are to the six months ended June 30, 2022 unless otherwise stated. • Total revenue of $685.5 million, up 29% from $533.0 million • Care Partners revenue of $639.9 million, up 31% from $488.6 million • Net income attributable to ApolloMed of $26.3 million, up 2% from $25.7 million
  evidence_url: https://www.sec.gov/Archives/edgar/data/1083446/000110465923089366/0001104659-23-089366-index.htm
- Earnings Releases
  Astrana Health, Inc. reported second quarter ended June 30, 2023 results: revenue $348.2 million, net income $13.2 million. Guidance reaffirmed.
  - Period: second quarter ended June 30, 2023
  - Revenue: $348.2 million
  - Net income: $13.2 million
  - Guidance: reaffirmed
  - Result: reported results
  source text: full-year 2023.” Financial Highlights for Second Quarter Ended June 30, 2023: All comparisons are to the quarter ended June 30, 2022 unless otherwise stated. • Total revenue of $348.2 million, up 29% from $269.7 million • Care Partners revenue of $325.2 million, up 32% from $247.3 million • Net income attributable to ApolloMed of $13.2 million, up 10% from $12.0
  evidence_url: https://www.sec.gov/Archives/edgar/data/1083446/000110465923089366/0001104659-23-089366-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.